| 1 |
Make up a missed lesson-New policy to ensure the interchangeability of generic drugs in China |
|
|
| Baobin Huang,Sarah L. Barber,Mingzhe Xu,Shuanghong Cheng |
|
| Pharmacology Research & Perspectives. 2017; 5(3): e00318 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Availability, Price, and Affordability of Selected Essential Medicines for Chronic Diseases in 11 Countries of the Asia Pacific Region: A Secondary Analysis |
|
|
| Haipeng Wang,Qiang Sun,Agnes Vitry,Tuan Anh Nguyen |
|
| Asia Pacific Journal of Public Health. 2017; 29(4): 268 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Inflated medicine prices in Vietnam: a qualitative study |
|
|
| Tuan Anh Nguyen,Rosemary Knight,Andrea Mant,Husna Razee,Geoffrey Brooks,Thu Ha Dang,Elizabeth Ellen Roughead |
|
| Health Policy and Planning. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Non-guideline-recommended prescribing of proton pump inhibitors: implications for the future and reducing over usage |
|
|
| Brian Godman,Joseph Fadare |
|
| Current Medical Research and Opinion. 2017; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Definition and Classification of Generic Drugs Across the World |
|
|
| Rafael Alfonso-Cristancho,Tatiana Andia,Tatiana Barbosa,Jonathan H. Watanabe |
|
| Applied Health Economics and Health Policy. 2015; 13(S1): 5 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Policy options for pharmaceutical pricing and purchasing: issues for low- and middle-income countries |
|
|
| T. A. Nguyen,R. Knight,E. E. Roughead,G. Brooks,A. Mant |
|
| Health Policy and Planning. 2014; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
